NOVEL ENTEROCOCCUS FAECIUM BACTERIOPHAGE ENT-FAP-4 AND USE FOR INHIBITING ENTEROCOCCUS FAECIUM PROLIFERATION OF SAME

The present invention relates to aSiphoviridaebacteriophage Ent-FAP-4 (Accession number: KCTC 12854BP) isolated from nature, which has the ability to specifically killEnterococcus faeciumand has the genome represented by SEQ ID NO: 1, a pharmaceutical composition containing theSiphoviridaebacterioph...

Full description

Saved in:
Bibliographic Details
Main Authors JUN, Soo Youn, PAIK, Hyoun Rok, YOON, Seong Jun, KANG, Sang Hyeon, SON, Jee Soo
Format Patent
LanguageEnglish
French
German
Published 01.01.2020
Subjects
BEER
BIOCHEMISTRY
CHEMISTRY
COMPOSITIONS THEREOF
CULTURE MEDIA
ENZYMOLOGY
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
MICROBIOLOGY
MICROORGANISMS OR ENZYMES
MUTATION OR GENETIC ENGINEERING
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS
SPIRITS
VINEGAR
WINE
Online AccessGet full text

Cover

More Information
Summary:The present invention relates to aSiphoviridaebacteriophage Ent-FAP-4 (Accession number: KCTC 12854BP) isolated from nature, which has the ability to specifically killEnterococcus faeciumand has the genome represented by SEQ ID NO: 1, a pharmaceutical composition containing theSiphoviridaebacteriophage Ent-FAP-4 as an active ingredient, and a method of preventing or treating a disease caused byEnterococcus faeciumusing the pharmaceutical composition.
Bibliography:Application Number: EP20180757092